These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5400112)

  • 21. Conjugation of catecholamines, a variable to be accounted for in human hypertension.
    Kuchel O; Buu NT; Hamet P; Larochelle P; Genest J
    Prog Biochem Pharmacol; 1980; 17():66-74. PubMed ID: 6937881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of various autonomic drugs on isolated, perfused mesenteric arteries.
    Rogers LA; Atkinson RA; Long JP
    J Pharmacol Exp Ther; 1966 Feb; 151(2):313-20. PubMed ID: 5932607
    [No Abstract]   [Full Text] [Related]  

  • 23. An experimental evaluation of the reputed influence of thyroxine on the cardiovascular effects of catecholamines.
    van der Schoot JB; Moran NC
    J Pharmacol Exp Ther; 1965 Sep; 149(3):336-45. PubMed ID: 5848044
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibitors of phenylethanolamine-N-methyltransferase. 2. Comparison of nonaromatic analogs of phenylethanolamines, 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline (SKF-64139) and 2,3-dichloro-alpha-methylbenzylamine: effects on rat brain and adrenal catecholamine content and blood pressure.
    Liang NY; Tessel RE; Grunewald GL; Borchardt RT
    J Pharmacol Exp Ther; 1982 Nov; 223(2):382-7. PubMed ID: 7131293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sixth National Burn Seminar. Adrenaline and noradrenaline excretion following burns.
    Harrison T
    J Trauma; 1967 Jan; 7(1):137-40. PubMed ID: 6018123
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of the cardiovascular effects of biogenic amines and their precursors in newborn and adult dogs.
    Privitera PJ; Loggie JM; Gaffney TE
    J Pharmacol Exp Ther; 1969 Apr; 166(2):293-8. PubMed ID: 5776987
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanism of supersensitivity to catecholamines following chloroquine.
    Pandya KH; Jindal MN; Kelkar VV
    Arzneimittelforschung; 1968 Jul; 18(7):786-90. PubMed ID: 5755820
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of inhibition of amine oxidase in vivo on administered adrenaline, noradrenaline, tyramine and serotonin.
    CORNE SJ; GRAHAM JD
    J Physiol; 1957 Feb; 135(2):339-49. PubMed ID: 13406744
    [No Abstract]   [Full Text] [Related]  

  • 29. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated plasma norepinephrine during cyclopropane anesthesia as a possible function of decreased amine metabolism.
    Gardier RW; Reier CE; Traber DL; Rowe HM; Hamelberg W
    Anesth Analg; 1967; 46(6):800-5. PubMed ID: 6070171
    [No Abstract]   [Full Text] [Related]  

  • 31. Refilling of noradrenaline stores in the prenylamine-depleted rabbit heart after injection of octopamine and tyramine.
    von Euler US; Lishajko F
    Life Sci; 1965 Jul; 4(14):1421-4. PubMed ID: 5322151
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardio-vascular effects of some derivatives of prenylamine (HOE 782, HOE 976 and HOE 674).
    Marmo E
    Arzneimittelforschung; 1971 Apr; 21(4):476-84. PubMed ID: 5108144
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibitors of phenylethanolamine N-methyltransferase. 1. Effects of 2-cycloocytyl-2-hydroxyethylamine on rat brain and adrenal catecholamine content and blood pressure.
    Liang NY; Tessel RE; Grunewald GL; Borchardt RT
    J Pharmacol Exp Ther; 1982 Nov; 223(2):375-81. PubMed ID: 7131292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals.
    Iversen LL; Glowinski J; Axelrod J
    J Pharmacol Exp Ther; 1966 Feb; 151(2):273-84. PubMed ID: 5932603
    [No Abstract]   [Full Text] [Related]  

  • 35. Kinetics of catecholamines and potassium, and heart rate during exercise testing in obese subjects. Heart rate regulation in obesity during exercise.
    Salvadori A; Fanari P; Giacomotti E; Palmulli P; Bolla G; Tovaglieri I; Luzi L; Longhini E
    Eur J Nutr; 2003 Aug; 42(4):181-7. PubMed ID: 12923648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular effects of LY134046, an inhibitor of norepinephrine N-methyltransferase, in spontaneously hypertensive rats.
    Hahn RA; Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1983 Jul; 226(1):39-45. PubMed ID: 6864549
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cerebral catecholamines in experimental excessive emotional stress].
    Belova TI; Kvetnanskiĭ R
    Usp Fiziol Nauk; 1981; 12(2):67-90. PubMed ID: 6115522
    [No Abstract]   [Full Text] [Related]  

  • 38. [The influence of a beta-adrenergic receptor blocking drug and a calcium antagonist on heart function in normal subjects (author's transl)].
    Wink K; Schalk T
    Arzneimittelforschung; 1981; 31(9):1474-8. PubMed ID: 6118163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic and autonomic effects of smokeless tobacco in healthy young men.
    Wolk R; Shamsuzzaman AS; Svatikova A; Huyber CM; Huck C; Narkiewicz K; Somers VK
    J Am Coll Cardiol; 2005 Mar; 45(6):910-4. PubMed ID: 15766828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Do catecholamines increase basal metabolism?].
    Strubelt O
    Arzneimittelforschung; 1968 Jun; 18(6):724-9. PubMed ID: 5755811
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.